Can agencies prove that regulations no longer hinder Grand Prix-level branded work?
When Monique Levy, one of the most-level-headed analysts in the pharma industry, calls attention to a mysterious phenomenon, you listen.
Apple's ResearchKit could accelerate the pace at which industry approaches start-ups building products in the patient-facing part of health tech
If you look at this as simply a tool to drive your brand, you've missed the point
How should pharma organize around adjacencies to therapeutics?
Will DIY and the mHealth movement be the catalysts driving change?
As these 40 standouts show, the industry is ready to move forward
There needs to be a greater effort put into the issue of adherence. What can academia, providers, pharma and payers do to address this pressing need?
Gen Y wants companies to stand for "Important missions and values"
Satisfaction levels among pharma-based respondents fell, but didn't exactly tank
Investment in healthcare IT stands at an all-time high. The government has spent billions to promote EHR adoption. Yet the physician wish list is a mile long, while hospitals and patients are not where they need to be. To peel back the layers of what we've all been waiting for in the Great Data Capture of the 21st Century, and to review the changes enabling the healthcare data ecosystem to coexist, MM&M presents this e-Book. Click here.
What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.